223 related articles for article (PubMed ID: 9918849)
21. The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors.
de Launoit Y; Audette M; Pelczar H; Plaza S; Baert JL
Oncogene; 1998 Apr; 16(16):2065-73. PubMed ID: 9572487
[TBL] [Abstract][Full Text] [Related]
22. Expression of trisomic proteins in Down syndrome model systems.
Spellman C; Ahmed MM; Dubach D; Gardiner KJ
Gene; 2013 Jan; 512(2):219-25. PubMed ID: 23103828
[TBL] [Abstract][Full Text] [Related]
23. Congenital heart disease reminiscent of partial trisomy 2p syndrome in mice transgenic for the transcription factor Lbh.
Briegel KJ; Baldwin HS; Epstein JA; Joyner AL
Development; 2005 Jul; 132(14):3305-16. PubMed ID: 15958514
[TBL] [Abstract][Full Text] [Related]
24. ERF: genomic organization, chromosomal localization and promoter analysis of the human and mouse genes.
Liu D; Pavlopoulos E; Modi W; Moschonas N; Mavrothalassitis G
Oncogene; 1997 Mar; 14(12):1445-51. PubMed ID: 9136988
[TBL] [Abstract][Full Text] [Related]
25. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.
Chang CH; Scott GK; Kuo WL; Xiong X; Suzdaltseva Y; Park JW; Sayre P; Erny K; Collins C; Gray JW; Benz CC
Oncogene; 1997 Apr; 14(13):1617-22. PubMed ID: 9129154
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil oxidative metabolism in Down syndrome patients with congenital heart defects.
Akinci O; Mihci E; Tacoy S; Kardelen F; Keser I; Aslan M
Environ Mol Mutagen; 2010 Jan; 51(1):57-63. PubMed ID: 19593803
[TBL] [Abstract][Full Text] [Related]
27. ets-1 and ets-2 proto-oncogene expression in human leukemia cells and cell lines.
Dreyfus F; Picard F; Gisselbrecht S; Varet B; Tambourin PE; Fichelson S
Nouv Rev Fr Hematol (1978); 1989; 31(3):217-21. PubMed ID: 2694094
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis.
Maroulakou IG; Papas TS; Green JE
Oncogene; 1994 Jun; 9(6):1551-65. PubMed ID: 8183549
[TBL] [Abstract][Full Text] [Related]
29. Using the quantitative competitive RT-PCR technique to analyze minute amounts of different mRNAs in small tissue samples.
Greber-Platzer S; Balcz B; Fleischmann C; Lubec G
Methods Mol Biol; 2002; 193():29-58. PubMed ID: 12325518
[No Abstract] [Full Text] [Related]
30. Determination of gene dosage by a quantitative adaptation of the polymerase chain reaction (gd-PCR): rapid detection of deletions and duplications of gene sequences.
Celi FS; Cohen MM; Antonarakis SE; Wertheimer E; Roth J; Shuldiner AR
Genomics; 1994 May; 21(2):304-10. PubMed ID: 8088823
[TBL] [Abstract][Full Text] [Related]
31. Transient myeloproliferative disorder with partial trisomy 21.
Takahashi T; Inoue A; Yoshimoto J; Kanamitsu K; Taki T; Imada M; Yamada M; Ninomiya S; Toki T; Terui K; Ito E; Shimada A
Pediatr Blood Cancer; 2015 Nov; 62(11):2021-4. PubMed ID: 26138905
[TBL] [Abstract][Full Text] [Related]
32. ETS family of genes in leukemia and Down syndrome.
Papas TS; Watson DK; Sacchi N; Fujiwara S; Seth AK; Fisher RJ; Bhat NK; Mavrothalassitis G; Koizumi S; Jorcyk CL
Am J Med Genet Suppl; 1990; 7():251-61. PubMed ID: 2149958
[TBL] [Abstract][Full Text] [Related]
33. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease.
Shim KS; Ferrando-Miguel R; Lubec G
J Neural Transm Suppl; 2003; (67):39-49. PubMed ID: 15068237
[TBL] [Abstract][Full Text] [Related]
34. Down syndrome congenital heart disease: a narrowed region and a candidate gene.
Barlow GM; Chen XN; Shi ZY; Lyons GE; Kurnit DM; Celle L; Spinner NB; Zackai E; Pettenati MJ; Van Riper AJ; Vekemans MJ; Mjaatvedt CH; Korenberg JR
Genet Med; 2001; 3(2):91-101. PubMed ID: 11280955
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis.
Wolvetang EJ; Bradfield OM; Hatzistavrou T; Crack PJ; Busciglio J; Kola I; Hertzog PJ
Neurobiol Dis; 2003 Dec; 14(3):349-56. PubMed ID: 14678752
[TBL] [Abstract][Full Text] [Related]
36. The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome.
Wolvetang EW; Bradfield OM; Tymms M; Zavarsek S; Hatzistavrou T; Kola I; Hertzog PJ
Biochim Biophys Acta; 2003 Jul; 1628(2):105-10. PubMed ID: 12890557
[TBL] [Abstract][Full Text] [Related]
37. Constitutive expression of c-fos and c-jun, overexpression of ets-2, and reduced expression of metastasis suppressor gene nm23-H1 in rheumatoid arthritis.
Dooley S; Herlitzka I; Hanselmann R; Ermis A; Henn W; Remberger K; Hopf T; Welter C
Ann Rheum Dis; 1996 May; 55(5):298-304. PubMed ID: 8660103
[TBL] [Abstract][Full Text] [Related]
38. Determination of the protooncogene ets-2 gene transcript in human brain at the atto-gram-level by the use of competitive RT/PCR.
Schatzmann-Turhani D; Greber-Platzer S; Cairns N; Lubec G
Amino Acids; 1999; 16(1):13-9. PubMed ID: 10078330
[TBL] [Abstract][Full Text] [Related]
39. [Detecting Down syndrome with a novel dual-color competitive quantitative fluorescent polymerase chain reaction method].
Wu P; Li QJ; Xia ZL; Zhang FQ; Yue LL; Chen QY; Wang H; Fan CY; Xia QJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):43-7. PubMed ID: 22311490
[TBL] [Abstract][Full Text] [Related]
40. Decreased AIRE expression and global thymic hypofunction in Down syndrome.
Lima FA; Moreira-Filho CA; Ramos PL; Brentani H; Lima Lde A; Arrais M; Bento-de-Souza LC; Bento-de-Souza L; Duarte MI; Coutinho A; Carneiro-Sampaio M
J Immunol; 2011 Sep; 187(6):3422-30. PubMed ID: 21856934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
